September 2, 2014


ESC Congress 2014 Hot Line Session: Favourable effect of Pradaxa® on kidney function over time compared to warfarin

  • RE-LY® sub-analysis shows that Pradaxa® treatment favourably affects kidney function1 deterioration over time compared to warfarin
  • Data provide additional support for long-term use of Pradaxa® in stroke prevention in non-valvular atrial fibrillation (NVAF)1

Non-US/Non-UK/Non-Canadian Media

New data presented today indicate that kidney function decline is less pronounced in patients with an irregular heartbeat (non-valvular"...

Continue Reading >

September 1, 2014


Boehringer Ingelheim to Present Comprehensive Data Supporting Broad Respiratory Portfolio in COPD, Asthma and IPF at ERS 2014

  • First presentation of positive results from pivotal, Phase III TONADO™ studies that supported recent regulatory submissions in Europe and US for tiotropium + olodaterol Respimat®*in COPD - the only fixed-dose combination (FDC) containing tiotropium
  • Data further confirming role of Spiriva® in delivering long-term benefits to COPD patients and in helping to establish COPD management strategy
  • Pooled Phase III data from large UniTinA-asthma® clinical trial programme showing improvement in both symptom control and risk of exacerbations across asthma severities...

    Continue Reading >

September 1, 2014


Extensive Experience in Clinical Practice and Expanding Research Programme Support use of Pradaxa® for Clot Prevention

  • Recent analysis of real world data document again the positive safety and efficacy profile of Pradaxa® as proven in clinical trials1-3
  • Final Phase of GLORIA™-AF Registry Program now initiated in North America and Europe
  • Extensive clinical research in established and new indications underway to improve patient care with Pradaxa®

For Non-US/Non-UK/Non-Canadian Media

Five years on from the first breakthrough"...

Continue Reading >

August 31, 2014


Ebola virus : emergency in Algeria borders, airports and ports

Algeria took strict prevention measures on its land borders, airports and ports in response to the deadly outbreak of Ebola virus disease in West Africa, Algerian health minister Abdelmalek Boudiaf said on Thursday.

« The virus outbreak could not happen at present. Necessary measures"...

Continue Reading >

August 27, 2014


New HeartSine AED Provides Automatic Shock Delivery

HeartSine® Technologies is pleased to announce the arrival of the samaritan® PAD 360P, a fully automatic AED (Automatic External Defibrillator) based on the company’s popular samaritan PAD 350P.

The HeartSine samaritan PAD 360P (SAM 360P) analyses the heart rhythm and delivers an electrical shock to a victim of Sudden Cardiac Arrest in order to restore the"...

Continue Reading >

August 26, 2014


Centaur Announces CFO Transition Plan

Centaur Guernsey L.P. Inc. (Centaur) today announced that Robert Hureau, Executive Vice President and Chief Financial Officer for Centaur and each of its operating subsidiaries Kinetic Concepts, Inc., LifeCell Corporation and Systagenix Wound Management, Limited, has notified the Company that he will be resigning to pursue another career opportunity. Mr. Hureau will continue in his current role until September 23, 2014. Following Mr. Hureau’s departure, Brian Busenlehner, Vice President, Corporate Controller, will serve"...

Continue Reading >

August 25, 2014


2015 to be year of hygiene, health system digitization, says minister

The year 2015 will be that of the implementation of the hygiene standards in health facilities, the widespread digitization of health system management and administration and the public health service, minister of Health, Population and hospital Reform, Abdelmalek Boudiaf said Sunday in El-Tarf.

Boudiaf said that after resorption of the problem of drug availability"...

Continue Reading >

August 25, 2014


New Pradaxa® Data to be Presented at the ESC Congress 2014

  • HOT LINE: New results from RE-LY® compare the effect of warfarin and Pradaxa® on kidney function in patients requiring anticoagulation
  • HOT LINE: GLORIA™-AF Registry Program benchmarks patient characteristics and antithrombotic use for stroke prevention in AF worldwide

For Non-US/Non-UK/Non-Canadian Media

New Pradaxa® (dabigatran etexilate) data for the treatment of a broad range of thromboembolic diseases will"...

Continue Reading >

August 23, 2014


FMD affected 23 provinces, epidemiological situation 'under control'

Foot and mouth disease (FMD) affected until Thursday 23 provinces while suspected cases were reported in the province of Mostaganem, said Boudoukha Hassan, Director General of the National Institute of Veterinary Medicine (INMV) who stressed the epidemiological situation is "stable."

The official said Tiaret is the last province affected by the disease onlast Sunday,"...

Continue Reading >

August 21, 2014


Clinical Study in the Journal of Clinical Oncology Reports Patients with Diffuse Large B-Cell Lymphoma Receiving Oral REVLIMID with Standard R-CHOP Achieved 98% Overall Response Rate and 80% Complete Response Rate

Celgene Corporation (NASDAQ:CELG) today announced that results of a study evaluating the combination of REVLIMID® (lenalidomide) with rituximab, cyclophosphamide, doxorubicin hydrochloride, vincristine sulfate and prednisone (R-CHOP) in untreated diffuse large b-cell lymphoma (DLBCL) were published online ahead of print in the Journal of Clinical Oncology.

In a phase"...

Continue Reading >